Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Winton Gibbons, Bill Moffitt, Rollie Carlson, Matt Winkler


Nanosphere said in recent filings with the US Securities and Exchange Commission that Winton Gibbons will resign from his role as senior vice president of business development at the end of April, and that Bill Moffitt will continue to serve as president and CEO under a new agreement that runs through 2013. The agreement provides Moffitt with a base salary of $458,000 with a possible bonus of up to $275,000. Nanosphere said it has no plans to refill Gibbons' position when he departs.

Asuragen said this week that Rollie Carlson has been appointed president and CEO. Carlson has served as the company's president and chief operating officer. Outgoing CEO Matt Winkler will continue to be chairman of the Austin, Texas-based company, as well as its chief scientific officer.

Carlson has been president of Asuragen since 2006. Prior to joining Asuragen, he held several positions at Abbott Laboratories, including vice president and general manager of the Vysis molecular diagnostic business.

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.